About 10000Iu Bionase L Asparaginase Injection
Discover the value-packed, best-seller 10000Iu Bionase L Asparaginase Injection, exclusively supplied by Zydus. This remarked therapy is specifically formulated for enlightened leukemia management, administering a lofty dose of 10000 IU L Asparaginase per vial. Crafted in India, each sterile, single-use box includes a reconstitution solvent for ease of intravenous or intramuscular administration. Recognized for its efficacy in acute lymphocytic leukemia, this trusted injection features a stable shelf life of 2 years. Experience distinct quality and peace of mind with this oncology solution, maintaining optimal enzyme activity and patient safety throughout storage and transport.
Versatile Features and Competitive Advantages of Bionase L Asparaginase
Bionase L Asparaginase 10000 IU Injection is remarked for its sterile, single-use vial format and normal fermentation smell. Primarily used for acute lymphocytic leukemia, it enlightens oncology care with lofty efficacy and consistent enzyme activity. Users benefit from included reconstitution solvent and stable shelf life. Its competitive advantages include exclusive Zydus manufacturing, ensured purity, and optimal pH. This product exemplifies reliable supply, making it trusted among hospitals, clinics, and wholesalers nationwide.
Export Markets, Secure Packaging, and Payment Flexibility
10000Iu Bionase L Asparaginase Injection enjoys considerable market value across both domestic and international mar. With expertly coordinated transport services, each box is rigorously packaged to preserve sterility and activity. The product appeals to exporters, traders, and wholesalers seeking quality oncology solutions. Flexible payment terms enhance convenience for various business models, while robust packaging and dedicated transport ensure remittance integrity and timely delivery to expanding markets worldwide.
FAQ's of 10000Iu Bionase L Asparaginase Injection:
Q: How is 10000Iu Bionase L Asparaginase Injection administered?
A: This injection is administered either intravenously or intramuscularly by healthcare professionals, following proper reconstitution with the provided solvent.
Q: What is the main benefit of using Bionase L Asparaginase for leukemia therapy?
A: The chief benefit lies in its targeted activity against acute lymphocytic leukemia, helping to arrest disease progression by utilizing its high enzymatic efficacy and exclusive formulation.
Q: When should the injection be stored and handled to maintain efficacy?
A: It should always be stored in a cool, dry place and protected from sunlight to preserve its enzymatic activity and sterility throughout the two-year shelf life.
Q: Where is 10000Iu Bionase L Asparaginase Injection manufactured and exported from?
A: This product is manufactured by Zydus in India and is distributed both domestically and in international markets.
Q: What is the typical process for reconstituting and preparing this injection?
A: Reconstitution involves adding the supplied solvent to the vial containing the white lyophilized powder, mixing until fully dissolved, and using it immediately as directed by a healthcare provider.